Comparison of Alcohol Withdrawal Outcomes in Patients Treated with Benzodiazepines Alone versus Adjunctive Phenobarbital: a Retrospective Cohort Study

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 297

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PJMT-4-1_004

تاریخ نمایه سازی: 17 تیر 1398

Abstract:

Background: For treatment of severe alcohol withdrawal syndrome, high dose benzodiazepines (BZDs) may cause delirium and over-sedation. Phenobarbital (PBT) is a long-acting barbiturate effective for the treatment of alcohol withdrawal. Given the potential benefits of PBT, we sought to investigate the effectiveness of PBT as adjunctive treatment for alcohol withdrawal. Methods: This was a retrospective cohort study on patients with a diagnosis of alcohol withdrawal who had a CIWA-Ar score > 10 treated with either BZDs alone (BZD alone group) or BZDs with adjunctive PBT (PBT-adjunct group). The patients received at least one dose of PBT in addition to BZDs (variable doses) in the PBT-adjunct group, and three doses of 20 mg diazepam equivalents within 6 hours in the BZD alone group. The primary endpoint was the proportion of patients with a CIWA-Ar score < 10 at 24 hours after initial treatment. Duration of withdrawal and cumulative dose of BZDs were also assessed. Results: Seven subjects in the adjunctive phenobarbital and 21 in the benzodiazepine group were included in the final analysis. Two patients (28.6%) in the PBT-adjunct group and 5 patients (23.8%) in the BZD only group achieved the primary endpoint, though the difference between the two groups was not statistically significant (P = 0.588). The median (IQR) duration of withdrawal symptoms was 44 (12-62) hours in the PBT-adjunct group compared to 53 (37-87) hours in the BZD only group, with no significant difference between the groups (P = 0.249). The median (IQR) cumulative BZD dose requirement (diazepam equivalent) in the PBT-adjunct group was significantly lower than BZD alone group (25 (20-226) vs. 326 (160-550) mg, P = 0.02). Conclusion: PBT appears to be a safe and effective alternative to BZDs for the treatment of alcohol withdrawal in non-critically ill patients and may be BZD sparing.

Authors

Lauren Z. Gashlin

Department of Pharmacy, University of Rochester Medical Center, Rochester, USA

Christine M. Groth

Department of Pharmacy, University of Rochester Medical Center, Rochester, USA

Timothy J. Wiegand

Department of Emergency Medicine, University of Rochester Medical Center, Rochester, USA

Elizabeth Ashley

Department of Pharmacy, University of Rochester Medical Center, Rochester, USA

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • World Health Organization (WHO). Global status report on alcohol and ...
  • Substance Abuse and Mental Health Services Administration. Results from the ...
  • Mayo-Smith MF, Beecher LH, Fischer TL. Management of Alcohol Withdrawal ...
  • Perry EC. Inpatient Management of Acute Alcohol Withdrawal Syndrome. CNS ...
  • Saitz R. Introduction to Alcohol Withdrawal. Alcohol Health Res World ...
  • Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. ...
  • Spies CD, Otter HE, Huske B, Sinha P, Neumann T, ...
  • Kramp P, Rafaelsen OJ. Delirium Tremens: A double blind comparison ...
  • Hendey GW, Dery RA, Barnes RL, Snowden B, Mentler P. ...
  • Gold JA, Rimal B, Nolan A, Nelson LS. A strategy ...
  • Ives TJ, Mooney AJ, Gwyther RE. Phenobarbital in the treatment ...
  • Young GP, Rores C, Murphy C, Dailey RH. Intravenous Phenobarbital ...
  • Hayner CE, Wuestefeld NL, Bolton PJ. Phenobarbital treatment in a ...
  • Rosenson J, Clements C, Simon B, Vieaux J, Graffman S, ...
  • Dill C, Shin S. High Dose Intravenous Benzodiazepine. Acad Emerg ...
  • University of Pittsburgh. Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal ...
  • Busto U, Sellers EM, Naranjo CA, Cappell H, Sanchez-Craig M, ...
  • Daeppen JB, Gache P, Landry U, Sekera E, Schweizer V, ...
  • Mihic SJ, Harris RA. Hypnotics and Sedatives. In: Brunton LL, ...
  • نمایش کامل مراجع